Phase 3 Study Results Supporting U.S. FDA and European Commission Approvals of STELARAÂ in the Treatment of Moderately to Severely Active Crohn's Disease Published in The New England Journal of Medicine

SPRING HOUSE Pa. Nov. 16 2016 PRNewswire Results from three pivotal Janssen Research & Development LLC Janssensponsored Phase 3 studies published today in The New England Journal of Medicine show that treatment with STELARAÂ ustekinumab induced an...